Fastest Earnings Growth Canadian Stocks — Health Care
Canadian stocks ranked by year-over-year earnings growth.
Updated November 11, 2026129 companiesTotal market cap $1177.5B
Showing 129 companies (CDRs hidden)
| Rank | Company | Symbol | Market Cap | P/E Ratio | Earnings Growth (YoY) |
|---|---|---|---|---|---|
| 1 | Azenta Inc | AZTA:US | $1.7B | - | 8777.80% |
| 2 | Covalon Technologies Ltd. | COV:V | $119M | 26.9 | 4225.30% |
| 3 | Hydreight Technologies Inc | NURS:V | $167M | 23.9 | 3874.60% |
| 4 | Astrana Health Inc | ASTH:US | $1.7B | 31.9 | 3331.00% |
| 5 | Quest PharmaTech Inc | QPT:V | $4M | 0.8 | 3010.20% |
| 6 | Sarepta Therapeutics Inc | SRPT:US | $1.9B | 891.0 | 2663.80% |
| 7 | Lifestance Health Group Inc | LFST:US | $5.2B | 76.5 | 2020.60% |
| 8 | Xeris Pharmaceuticals Inc | XERS:US | $2.9B | - | 1616.20% |
| 9 | DRI Healthcare Trust | DHT-U:TO | $744M | 12.5 | 1521.40% |
| 10 | DRI Healthcare Trust | DHT-UN:TO | $1.1B | 13.2 | 1521.40% |
| 11 | Medline Inc. Class A Common Stock | MDLN:US | $53.6B | 92.5 | 1087.70% |
| 12 | CareDx Inc | CDNA:US | $4.1B | 33.1 | 1066.70% |
| 13 | Ligand Pharmaceuticals Incorporated | LGND:US | $6.3B | 126.2 | 825.00% |
| 14 | Amotiv Limited | AOV:TO | $577M | - | 800.00% |
| 15 | Medicure Inc | MPH:V | $39M | - | 709.60% |
| 16 | The Joint Corp | JYNT:US | $94M | 31.1 | 652.60% |
| 17 | Alnylam Pharmaceuticals Inc | ALNY:US | $20.9B | 7.9 | 633.50% |
| 18 | Innoviva Inc | INVA:US | $1.4B | 8.1 | 590.40% |
| 19 | Organogenesis Holdings Inc | ORGO:US | $118M | - | 555.20% |
| 20 | NeuPath Health Inc | NPTH:V | $32M | 28.0 | 537.10% |
| 21 | Corcept Therapeutics Incorporated | CORT:US | $8.2B | 54.8 | 531.30% |
| 22 | Oramed Pharmaceuticals Inc | ORMP:US | $166M | 1.0 | 493.50% |
| 23 | Sol Gel Technologies Ltd | SLGL:US | $202M | - | 487.60% |
| 24 | Pacira BioSciences, Inc. | PCRX:US | $1.5B | 39.2 | 483.30% |
| 25 | Varex Imaging Corp | VREX:US | $783M | 34.8 | 453.40% |
| 26 | Sensus Healthcare Inc | SRTS:US | $47M | - | 433.30% |
| 27 | Creative Medical Technology Holdings Inc | CELZ:US | $5M | - | 358.90% |
| 28 | The Cooper Companies, Inc | COO:US | $11.9B | 21.4 | 357.10% |
| 29 | Sinovac Biotech Ltd | SVA:US | $642M | 6.7 | 354.80% |
| 30 | Protagonist Therapeutics Inc | PTGX:US | $8.6B | 27.9 | 351.30% |
| 31 | SBC Medical Group Holdings Incorporated | SBC:US | $541M | 10.7 | 338.90% |
| 32 | Daxor Corporation | DXR:US | $49M | 7.7 | 329.30% |
| 33 | Sucro Limited | SUGR:V | $216M | 3.9 | 325.00% |
| 34 | Axogen Inc | AXGN:US | $3.0B | - | 300.00% |
| 35 | Certara Inc | CERT:US | $1.8B | - | 285.20% |
| 36 | Atea Pharmaceuticals Inc | AVIR:US | $346M | - | 264.10% |
| 37 | ImmuCell Corporation | ICCC:US | $93M | 146.0 | 259.90% |
| 38 | Indivior PLC Ordinary Shares | INDV:US | $4.3B | 10.2 | 239.40% |
| 39 | Supernus Pharmaceuticals, Inc. | SUPN:US | $1.6B | - | 239.40% |
| 40 | BeOne Medicines AG | ONC:US | $47.7B | 53.5 | 212.50% |
| 41 | Airsculpt Technologies Inc | AIRS:US | $39M | - | 200.00% |
| 42 | CardioComm Solutions Inc. | EKG:V | $2M | - | 188.50% |
| 43 | Vericel Corp Ord | VCEL:US | $2.8B | 85.3 | 170.00% |
| 44 | Gyre Therapeutics Inc. | GYRE:US | $509M | - | 166.20% |
| 45 | WELL Health Technologies Corp | WELL:TO | $1.1B | 212.5 | 158.90% |
| 46 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX:US | $7.4B | 53.2 | 157.10% |
| 47 | Decibel Cannabis Company Inc | DB:V | $79M | - | 154.00% |
| 48 | Immunocore Holdings Ltd | IMCR:US | $1.6B | - | 150.00% |
| 49 | CareCloud, Inc. | CCLD:US | $107M | 20.9 | 146.20% |
| 50 | Align Technology Inc | ALGN:US | $11.7B | 24.2 | 143.60% |
| 51 | Kiniksa Pharmaceuticals Ltd | KNSA:US | $7.8B | 74.8 | 143.50% |
| 52 | Alignment Healthcare LLC | ALHC:US | $1.5B | 52.4 | 142.90% |
| 53 | NexgenRX Inc. | NXG:V | $47M | 22.0 | 140.00% |
| 54 | Bausch Health Companies Inc | BHC:TO | $4.4B | - | 139.60% |
| 55 | InnovAge Holding Corp | INNV:US | $1.3B | 153.5 | 136.70% |
| 56 | Amphastar P | AMPH:US | $1.2B | 13.1 | 135.10% |
| 57 | BioCryst Pharmaceuticals Inc | BCRX:US | $2.0B | - | 133.30% |
| 58 | NeoGenomics Inc | NEO:US | $2.3B | - | 130.60% |
| 59 | Progyny Inc | PGNY:US | $2.6B | 32.0 | 113.30% |
| 60 | Omnicell Inc | OMCL:US | $1.7B | 38.9 | 100.10% |
| 61 | Privia Health Group Inc | PRVA:US | $3.1B | 93.9 | 100.00% |
| 62 | MiMedx Group Inc | MDXG:US | $483M | - | 99.50% |
| 63 | Sienna Senior Living Inc | SIA:TO | $2.3B | 38.8 | 93.20% |
| 64 | Inogen Inc | INGN:US | $160M | - | 87.30% |
| 65 | BrightSpring Health Services, Inc. Common Stock | BTSG:US | $13.8B | 49.0 | 82.00% |
| 66 | Spero Therapeutics Inc | SPRO:US | $60M | 7.4 | 75.30% |
| 67 | Pharming Group NV | PHAR:US | $870M | 38.4 | 74.90% |
| 68 | Cytek Biosciences Inc | CTKB:US | $762M | - | 73.50% |
| 69 | Bioventus Inc | BVS:US | $727M | 13.1 | 69.70% |
| 70 | Insulet Corporation | PODD:US | $10.4B | 23.9 | 63.70% |
| 71 | Clene Inc. | CLNN:US | $57M | - | 61.40% |
| 72 | CytomX Therapeutics Inc | CTMX:US | $477M | - | 60.60% |
| 73 | Brainsway Ltd | BWAY:US | $449M | 48.5 | 59.80% |
| 74 | Vir Biotechnology Inc | VIR:US | $2.3B | - | 58.50% |
| 75 | Veracyte Inc | VCYT:US | $2.1B | 16.8 | 58.30% |
| 76 | Ironwood Pharmaceuticals Inc | IRWD:US | $727M | 4.9 | 57.00% |
| 77 | Pennant Group Inc | PNTG:US | $1.3B | 35.9 | 52.90% |
| 78 | Merit Medical Systems Inc | MMSI:US | $5.2B | 32.7 | 52.20% |
| 79 | argenx NV ADR | ARGX:US | $58.3B | 32.1 | 50.60% |
| 80 | Simulations Plus Inc | SLP:US | $374M | 46.3 | 46.70% |
| 81 | ADMA Biologics Inc | ADMA:US | $2.8B | 16.6 | 46.70% |
| 82 | Illumina Inc | ILMN:US | $33.4B | 38.0 | 45.90% |
| 83 | Abcellera Biologics Inc | ABCL:US | $3.8B | - | 45.90% |
| 84 | Halozyme Therapeutics Inc | HALO:US | $11.7B | 25.9 | 40.60% |
| 85 | Premier Health of America Inc | PHA:V | $0M | - | 39.80% |
| 86 | Biosyent Inc. | RX:V | $199M | 20.8 | 39.20% |
| 87 | GE HealthCare Technologies Inc. | GEHC:US | $38.0B | 17.8 | 39.00% |
| 88 | Aveanna Healthcare Holdings Inc | AVAH:US | $2.9B | 10.5 | 38.50% |
| 89 | Incyte Corporation | INCY:US | $24.8B | 62.2 | 37.70% |
| 90 | Regeneron Pharmaceuticals Inc | REGN:US | $93.6B | 20.0 | 35.50% |
| 91 | ANI Pharmaceuticals Inc | ANIP:US | $1.5B | 13.5 | 33.40% |
| 92 | Grifols SA ADR | GRFS:US | $5.7B | 10.2 | 32.90% |
| 93 | Co-Diagnostics, Inc. Common Stock | CODX:US | $2M | - | 30.80% |
| 94 | OraSure Technologies Inc | OSUR:US | $243M | - | 29.60% |
| 95 | Crescita Therapeutics Inc | CTX:TO | $15M | - | 28.70% |
| 96 | Medirom Healthcare Technologies Inc | MRM:US | $2M | 0.7 | 27.80% |
| 97 | Henry Schein Inc | HSIC:US | $9.5B | 23.6 | 26.20% |
| 98 | Extendicare Inc | EXE:TO | $2.6B | 20.3 | 26.00% |
| 99 | Medpace Holdings Inc | MEDP:US | $18.3B | 36.3 | 25.40% |
| 100 | UFP Technologies Inc | UFPT:US | $2.5B | 32.6 | 25.10% |
| 101 | Addus HomeCare Corporation | ADUS:US | $2.3B | 20.7 | 24.20% |
| 102 | CorVel Corp | CRVL:US | $4.1B | 34.6 | 24.10% |
| 103 | The Ensign Group Inc | ENSG:US | $10.6B | 27.1 | 23.90% |
| 104 | Exelixis Inc | EXEL:US | $17.5B | 21.5 | 23.20% |
| 105 | Kamada | KMDA:US | $445M | 20.3 | 23.10% |
| 106 | Viemed Healthcare Inc | VMD:US | $339M | 23.6 | 22.20% |
| 107 | Amgen Inc | AMGN:US | $249.0B | 26.7 | 19.40% |
| 108 | Option Care Health Inc | OPCH:US | $4.7B | 23.0 | 18.80% |
| 109 | Iradimed Co | IRMD:US | $1.1B | 46.2 | 18.30% |
| 110 | IDEXX Laboratories Inc | IDXX:US | $55.7B | 47.6 | 17.90% |
| 111 | Sotera Health Co | SHC:US | $4.6B | 26.7 | 17.60% |
| 112 | NRC Health | NRC:US | $566M | 98.8 | 16.70% |
| 113 | Dentsply Sirona Inc | XRAY:US | $1.9B | - | 15.20% |
| 114 | HealthEquity Inc | HQY:US | $8.6B | 37.4 | 14.70% |
| 115 | rYojbaba Co., Ltd. Common Shares | RYOJ:US | $29M | 250.0 | 11.80% |
| 116 | Phibro Animal Health Corporation | PAHC:US | $1.4B | 13.2 | 10.80% |
| 117 | Arrowhead Pharmaceuticals Inc | ARWR:US | $6.9B | - | 9.80% |
| 118 | Sanofi ADR | SNY:US | $112.7B | 23.4 | 9.40% |
| 119 | DocGo Inc | DCGO:US | $24M | - | 9.00% |
| 120 | Agilent Technologies Inc | A:US | $43.3B | 29.7 | 8.50% |
| 121 | Utah Medical Products Inc | UTMD:US | $207M | 21.8 | 6.80% |
| 122 | Medexus Pharmaceuticals Inc | MDP:TO | $161M | - | 6.80% |
| 123 | Adapthealth Corp | AHCO:US | $1.0B | - | 6.70% |
| 124 | CorMedix Inc | CRMD:US | $415M | 2.6 | 6.70% |
| 125 | Arcutis Biotherapeutics Inc | ARQT:US | $3.2B | 116.1 | 3.30% |
| 126 | Jazz Pharmaceuticals PLC | JAZZ:US | $15.1B | 69.5 | 3.20% |
| 127 | Anbio Biotechnology Class A Ordinary Shares | NNNN:US | $179M | 27.2 | 2.80% |
| 128 | DexCom Inc | DXCM:US | $30.2B | 31.9 | 2.60% |
| 129 | Integra LifeSciences Holdings | IART:US | $1.0B | 78.9 | 0.40% |
Frequently Asked Questions
Which Canadian company ranks #1 by earnings growth (yoy) in Health Care?
As of November 11, 2026, Azenta Inc (AZTA:US) ranks #1 in Health Care at 8777.80%.
How often is this ranking updated?
The table is rebuilt from live fundamentals throughout the day. This page currently shows data as of November 11, 2026.
How many companies are in this earnings growth (yoy) list?
This view shows 129 Canadian listings in Health Care. Canadian Depositary Receipts are hidden by default.
What is the difference between TSX and TSXV?
The Toronto Stock Exchange (TSX) lists larger established companies. The TSX Venture Exchange (TSXV) lists earlier-stage companies. Use the exchange filter to separate them.
Explore More Stock Rankings
Largest by Market Cap
Companies with the highest market capitalization
Largest by Revenue
Companies with the highest annual revenue
Highest Profit Margin
Most profitable companies by net margin
Highest Return on Equity
Companies generating the best returns for shareholders
Highest Return on Assets
Most efficient companies at using assets
Highest Dividend Yield
Top dividend-paying stocks
Fastest Revenue Growth
Companies with strongest year-over-year revenue growth